Why is Now the Right Time to Modernise the Eu Variations System?

AMR Industry Alliance 2020 Progress Report

Biosimilars in the EU – Information guide for healthcare professionals – now available in 23 languages

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

Improving healthcare delivery in hospitals by optimized utilization of medicines

Positioning Statements on Physician-led Switching for Biosimilar Medicines

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

Annual Medicines for Europe and IGBA Conference 2019

15th Legal Affairs Conference